{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:27:29Z","timestamp":1777577249023,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T00:00:00Z","timestamp":1472169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T00:00:00Z","timestamp":1472169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Connective tissue growth factor (CTGF) has been recognized as a central mediator and promising therapeutic target in hepatic fibrosis. In this study, we generated a novel virus-like particle (VLP) CTGF vaccine by inserting the 138\u2013159 amino acid (aa) fragment of CTGF into the central c\/e1 epitope of C-terminus truncated hepatitis B virus core antigen (HBc, aa 1\u2013149) using a prokaryotic expression system. Immunization of BALB\/c mice with the VLP vaccine efficiently elicited the production of anti-CTGF neutralizing antibodies. Vaccination with this CTGF vaccine significantly protected BALB\/c mice from carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>)-induced hepatic fibrosis, as indicated by decreased hepatic hydroxyproline content and lower fibrotic score. CCl<jats:sub>4<\/jats:sub>intoxication-induced hepatic stellate cell activation was inhibited by the vaccination, as indicated by decreased \u03b1-smooth muscle actin expression and Smad2 phosphorylation. Vaccination against CTGF also attenuated the over-expression of some profibrogenic factors, such as CTGF, transforming growth factor-\u03b21, platelet-derived growth factor-B and tissue inhibitor of metalloproteinase-1 in the fibrotic mouse livers, decreased hepatocyte apoptosis and accelerated hepatocyte proliferation in the fibrotic mouse livers. Our results clearly indicate that vaccination against CTGF inhibits fibrogenesis, alleviates hepatocyte apoptosis and facilitate hepatic regeneration. We suggest that the vaccine should be developed into an effective therapeutic measure for hepatic fibrosis.<\/jats:p>","DOI":"10.1038\/srep32155","type":"journal-article","created":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T09:46:36Z","timestamp":1472204796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A virus-like particle-based connective tissue growth factor vaccine suppresses carbon tetrachloride-induced hepatic fibrosis in mice"],"prefix":"10.1038","volume":"6","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hou-Qiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,26]]},"reference":[{"key":"BFsrep32155_CR1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655\u20131669 (2008).","journal-title":"Gastroenterology"},{"key":"BFsrep32155_CR2","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2008.01826.x","volume":"28","author":"OA Gressner","year":"2008","unstructured":"Gressner, O. A. & Gressner, A. M. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int. 28, 1065\u20131079 (2008).","journal-title":"Liver Int."},{"key":"BFsrep32155_CR3","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2741\/4067","volume":"17","author":"G Huang","year":"2012","unstructured":"Huang, G. & Brigstock, D. R. Regulation of hepatic stellate cells by connective tissue growth factor. Front. Biosci. ( Landmark Ed) 17, 2495\u20132507 (2012).","journal-title":"Front. Biosci."},{"key":"BFsrep32155_CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/CS20140264","volume":"128","author":"S Kubota","year":"2015","unstructured":"Kubota, S. & Takigawa, M. Cellular and molecular actions of CCN2\/CTGF and its role under physiological and pathological conditions. Clin. Sci. (Lond) 128, 181\u2013196 (2015).","journal-title":"Clin. Sci. (Lond)"},{"key":"BFsrep32155_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cytogfr.2008.01.002","volume":"19","author":"X Shi-Wen","year":"2008","unstructured":"Shi-Wen, X., Leask, A. & Abraham, D. Regulation and function of connective tissue growth factor\/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 19, 133\u2013144 (2008).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFsrep32155_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(03)00115-3","volume":"26","author":"AW Rachfal","year":"2003","unstructured":"Rachfal, A. W. & Brigstock, D. R. Connective tissue growth factor (CTGF\/CCN2) in hepatic fibrosis. Hepatol. Res. 26, 1\u20139 (2003).","journal-title":"Hepatol. Res."},{"key":"BFsrep32155_CR7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.510300425","volume":"30","author":"V Paradis","year":"1999","unstructured":"Paradis, V. et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30, 968\u2013976 (1999).","journal-title":"Hepatology"},{"key":"BFsrep32155_CR8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/hep.23102","volume":"50","author":"Z Tong","year":"2009","unstructured":"Tong, Z. et al. Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology 50, 939\u2013947 (2009).","journal-title":"Hepatology"},{"key":"BFsrep32155_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1067-1927.2004.012112.x-1","volume":"12","author":"K Uchio","year":"2004","unstructured":"Uchio, K., Graham, M., Dean, N. M., Rosenbaum, J. & Desmouli\u00e8re, A. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis. Wound Repair Regen. 12, 60\u201366 (2004).","journal-title":"Wound Repair Regen."},{"key":"BFsrep32155_CR10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/jgm.894","volume":"8","author":"G Li","year":"2006","unstructured":"Li, G. et al. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J. Gene Med. 8, 889\u2013900 (2006).","journal-title":"J. Gene Med."},{"key":"BFsrep32155_CR11","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.gt.3302929","volume":"14","author":"J George","year":"2007","unstructured":"George, J. & Tsutsumi, M. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther. 14, 790\u2013803 (2007).","journal-title":"Gene Ther."},{"key":"BFsrep32155_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10238-013-0229-6","volume":"14","author":"C Hao","year":"2014","unstructured":"Hao, C. et al. Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo . Clin. Exp. Med. 14, 141\u2013150 (2014).","journal-title":"Clin. Exp. Med."},{"key":"BFsrep32155_CR13","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1186\/1755-1536-5-S1-S24","volume":"5","author":"KE Lipson","year":"2012","unstructured":"Lipson, K. E., Wong, C., Teng, Y. & Spong, S. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair 5, S24 (2012).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFsrep32155_CR14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-4-4","volume":"4","author":"Q Wang","year":"2011","unstructured":"Wang, Q. et al. Cooperative interaction of CTGF and TGF-\u03b2 in animal models of fibrotic disease. Fibrogenesis Tissue Repair 4, 4 (2011).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFsrep32155_CR15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.200610-1405OC","volume":"176","author":"Y Ma","year":"2007","unstructured":"Ma, Y. et al. Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice. Am. J. Respir. Crit. Care Med. 176, 439\u2013445 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFsrep32155_CR16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1398-9995.2007.01384.x","volume":"62","author":"Y Ma","year":"2007","unstructured":"Ma, Y. et al. Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice. Allergy 62, 675\u2013682 (2007).","journal-title":"Allergy"},{"key":"BFsrep32155_CR17","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1016\/j.vaccine.2007.09.009","volume":"25","author":"Y Ma","year":"2007","unstructured":"Ma, Y., Ma, A. G. & Peng, Z. A potential immunotherapy approach: mucosal immunization with an IL-13 peptide-based and virus-like particle vaccine in a mouse asthma model. Vaccine 25, 8091\u20138099 (2007).","journal-title":"Vaccine"},{"key":"BFsrep32155_CR18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1365-2222.2007.02741.x","volume":"37","author":"Z Peng","year":"2007","unstructured":"Peng, Z. et al. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents. Clin. Exp. Allergy 37, 1040\u20131048 (2007).","journal-title":"Clin. Exp. Allergy"},{"key":"BFsrep32155_CR19","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1016\/j.vaccine.2009.09.058","volume":"27","author":"QD Guan","year":"2009","unstructured":"Guan, Q. D. et al. Development of recombinant vaccines against IL-12\/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis. Vaccine 27, 7096\u20137104 (2009).","journal-title":"Vaccine"},{"key":"BFsrep32155_CR20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ibd.21167","volume":"16","author":"Y Ma","year":"2010","unstructured":"Ma, Y. et al. Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis. Inflamm. Bowel Dis. 16, 1040\u20131050 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFsrep32155_CR21","first-page":"17","volume":"12","author":"PC Rodr\u00edguez","year":"2010","unstructured":"Rodr\u00edguez, P. C., Rodr\u00edguez, G., Gonz\u00e1lez, G. & Lage, A. Clinical development and perspectives of CIMAvax EGF, Cuban vaccine for non-small-cell lung cancer therapy. MEDICC Rev. 12, 17\u201323 (2010).","journal-title":"MEDICC Rev."},{"key":"BFsrep32155_CR22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2119\/molmed.2010.00252","volume":"17","author":"Q Guan","year":"2011","unstructured":"Guan, Q. et al. Targeting IL-12\/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis. Mol. Med. 17, 646\u2013656 (2011).","journal-title":"Mol. Med."},{"key":"BFsrep32155_CR23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/0008-5472.CAN-10-2292","volume":"71","author":"T Klamp","year":"2011","unstructured":"Klamp, T. et al. Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastases. Cancer Res. 71, 516\u2013527 (2011).","journal-title":"Cancer Res."},{"key":"BFsrep32155_CR24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.molimm.2012.05.015","volume":"52","author":"CJ Lin","year":"2012","unstructured":"Lin, C. J. et al. CvarepsilonmX peptide-carrying HBcAg virus-like particles induced antibodies that down-regulate mIgE-B lymphocytes. Mol. Immunol. 52, 190\u2013119 (2012).","journal-title":"Mol. Immunol."},{"key":"BFsrep32155_CR25","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2217\/imt.12.129","volume":"4","author":"Q Guan","year":"2012","unstructured":"Guan, Q., Weiss, C. R., Qing, G., Ma, Y. & Peng, Z. An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo . Immunotherapy 4, 1799\u20131807 (2012).","journal-title":"Immunotherapy"},{"key":"BFsrep32155_CR26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1124\/jpet.112.194357","volume":"342","author":"ZM Hao","year":"2012","unstructured":"Hao, Z. M. et al. Vaccination with platelet-derived growth factor B kinoids inhibits CCl4-induced hepatic fibrosis in mice. J. Pharmacol. Exp. Ther. 342, 835\u2013842 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep32155_CR27","doi-asserted-by":"crossref","first-page":"e82190","DOI":"10.1371\/journal.pone.0082190","volume":"8","author":"XB Fan","year":"2013","unstructured":"Fan, X. B. et al. Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-\u03b21. PLoS One 8, e82190 (2013).","journal-title":"PLoS One"},{"key":"BFsrep32155_CR28","doi-asserted-by":"crossref","first-page":"e113465","DOI":"10.1371\/journal.pone.0113465","volume":"9","author":"P Durez","year":"2014","unstructured":"Durez, P. et al. Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: A phase II randomized, controlled clinical trial. PLoS One 9, e113465 (2014).","journal-title":"PLoS One"},{"key":"BFsrep32155_CR29","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/hep.22850","volume":"49","author":"OA Gressner","year":"2009","unstructured":"Gressner, O. A. et al. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes\u2014but without modulating bone morphogenetic protein 7 signaling. Hepatology 49, 2021\u20132030 (2009).","journal-title":"Hepatology"},{"key":"BFsrep32155_CR30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0083-6729(05)70003-0","volume":"70","author":"AW Rachfal","year":"2005","unstructured":"Rachfal, A. W. & Brigstock, D. R. Structural and functional properties of CCN proteins. Vitam. Horm. 70, 69\u2013103 (2005).","journal-title":"Vitam. Horm."},{"key":"BFsrep32155_CR31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hci078","volume":"98","author":"M Dziadzio","year":"2005","unstructured":"Dziadzio, M. et al. N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. Q. J. M. 98, 485\u2013492 (2005).","journal-title":"Q. J. M."},{"key":"BFsrep32155_CR32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1096\/fj.04-3217com","volume":"19","author":"GR Grotendorst","year":"2005","unstructured":"Grotendorst, G. R. & Duncan, M. R. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB. J. 19, 729\u2013738 (2005).","journal-title":"FASEB. J."},{"key":"BFsrep32155_CR33","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.febslet.2006.01.061","volume":"580","author":"M Hoshijima","year":"2006","unstructured":"Hoshijima, M. et al. CT domain of CCN2\/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS. Lett. 580, 1376\u20131382 (2006).","journal-title":"FEBS. Lett."},{"key":"BFsrep32155_CR34","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1242\/dev.01045","volume":"131","author":"S Mercurio","year":"2004","unstructured":"Mercurio, S., Latinkic, B., Itasaki, N., Krumlauf, R. & Smith, J. C. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131, 2137\u20132147 (2004).","journal-title":"Development"},{"key":"BFsrep32155_CR35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ncb826","volume":"4","author":"JG Abreu","year":"2002","unstructured":"Abreu, J. G., Ketpura, N. I., Reversade, B. & De Robertis, E. M. Connective tissue growth factor (CTGF) modulates cell signalling by BMP and TGF- \u03b2. Nat. Cell Biol. 4, 599\u2013604 (2002).","journal-title":"Nat. Cell Biol."},{"key":"BFsrep32155_CR36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0014-5793(01)02656-4","volume":"502","author":"S Dooley","year":"2001","unstructured":"Dooley, S. et al. Transforming growth factor \u03b2 signal transduction in hepatic stellate cells via Smad2\/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts: TGF\u03b2 signal transduction during transdifferentiation of hepatic stellate cells. FEBS. Letters 502, 4\u201310 (2001).","journal-title":"FEBS. Letters"},{"key":"BFsrep32155_CR37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jcp.10319","volume":"196","author":"FF Safadi","year":"2003","unstructured":"Safadi, F. F. et al. Expression of connective tissue growth factor in bone: Its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo . J. Cell Physiol. 196, 51\u201362 (2003).","journal-title":"J. Cell Physiol."},{"key":"BFsrep32155_CR38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000055339","volume":"61","author":"T Shimo","year":"2001","unstructured":"Shimo, T. et al. Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology 61, 315\u2013322 (2001).","journal-title":"Oncology"},{"key":"BFsrep32155_CR39","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/j.1582-4934.2008.00260.x","volume":"12","author":"OA Gressner","year":"2008","unstructured":"Gressner, O. A. et al. Activation of TGF-\u03b2 within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor. J. Cell Mol. Med. 12, 2717\u20132730 (2008).","journal-title":"J. Cell Mol. Med."},{"key":"BFsrep32155_CR40","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.LAB.0000017365.18894.D3","volume":"82","author":"V Paradis","year":"2002","unstructured":"Paradis, V. et al. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab. Invest. 82, 767\u2013774 (2002).","journal-title":"Lab. Invest."},{"key":"BFsrep32155_CR41","doi-asserted-by":"crossref","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","volume":"288","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Transforming growth factor-\u03b2 (TGF-\u03b2)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation. J. Biol. Chem. 288, 30708\u201330719 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32155_CR42","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/jhep.2002.35625","volume":"36","author":"H Yoshiji","year":"2002","unstructured":"Yoshiji, H. et al. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36, 850\u2013860 (2002).","journal-title":"Hepatology"},{"key":"BFsrep32155_CR43","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1074\/jbc.M111490200","volume":"277","author":"FR Murphy","year":"2002","unstructured":"Murphy, F. R. et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects of matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J. Biol. Chem. 277, 11069\u201311076 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32155_CR44","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","volume":"282","author":"M Zeisberg","year":"2007","unstructured":"Zeisberg, M. et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337\u201323347 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32155_CR45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.23368","volume":"51","author":"K Taura","year":"2010","unstructured":"Taura, K. et al. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51, 1027\u20131036 (2010).","journal-title":"Hepatology"},{"key":"BFsrep32155_CR46","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/mt.2012.148","volume":"20","author":"ZM Hao","year":"2012","unstructured":"Hao, Z. M., Cai, M., Lv, Y. F., Huang, Y. H. & Li, H. H. Oral administration of recombinant adeno-associated virus-mediated bone morphogenetic protein-7 suppresses CCl4-induced hepatic fibrosis in mice. Mol. Ther. 20, 2043\u20132051 (2012).","journal-title":"Mol. Ther."},{"key":"BFsrep32155_CR47","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/hep.20618","volume":"41","author":"FF Mohammed","year":"2005","unstructured":"Mohammed, F. F. et al. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 41, 857\u2013867 (2005).","journal-title":"Hepatology"},{"key":"BFsrep32155_CR48","first-page":"225","volume":"79","author":"DC Martin","year":"1999","unstructured":"Martin, D. C. et al. Transgenic TIMP-1 inhibits simian virus 40T-antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Lab Invest. 79, 225\u2013234 (1999).","journal-title":"Lab Invest."},{"key":"BFsrep32155_CR49","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1073\/pnas.85.14.5126","volume":"85","author":"WE Russell","year":"1988","unstructured":"Russell, W. E., Coffey, R. J., Jr, Ouellette, A. J. & Moses, H. L. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA 85, 5126\u20135130 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep32155_CR50","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/MCB.22.5.1369-1378.2002","volume":"22","author":"BC Kim","year":"2002","unstructured":"Kim, B. C., Mamura, M., Choi, K. S., Calabretta, B. & Kim, S. J. Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Mol. Cell Biol. 22, 1369\u20131378 (2002).","journal-title":"Mol. Cell Biol."},{"key":"BFsrep32155_CR51","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1038\/sj.onc.1208475","volume":"24","author":"J Romero-Gallo","year":"2005","unstructured":"Romero-Gallo, J. et al. Inactivation of TGF-\u03b2 signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. Oncogene 24, 3028\u20133041 (2005).","journal-title":"Oncogene"},{"key":"BFsrep32155_CR52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K shak","year":"1995","unstructured":"shak, K. et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696\u2013699 (1995).","journal-title":"J. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep32155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32155","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T14:29:52Z","timestamp":1749565792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep32155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,26]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,31]]}},"alternative-id":["BFsrep32155"],"URL":"https:\/\/doi.org\/10.1038\/srep32155","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,26]]},"assertion":[{"value":"29 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32155"}}